How long does it take for adagrasib to take effect?

Adagrasib (Adagrasib) is a drug used to treat certain types of tumors. It belongs to a class of drugs called KRAS G12C inhibitors. The onset of action of adagrasib varies based on individual differences and treatment circumstances. Based on clinical studies, treatment with adagrasiib typically takes weeks to months to see significant results.

Prior to the approval of KRAS G12C inhibitors, patients with this mutation had limited second-line or second-line treatment options. Studies have shown that adagrasib can cause some responses in tumors during the first treatment cycle, such as shrinking or stopping growth. However, it may take longer and require more treatment cycles to see full treatment effects. Based on data from the phase 1/2 KRYSTAL-1 trial (NCT03785249), adagrasib demonstrated an objective response rate of 43% in patients with KRASG12C-mutated non-small cell lung cancer, with a median duration of response of 8.5 months.

Because every patient's situation is different, treatment results will vary. Some patients may respond quickly to adagrasiib, while others may take longer to see results. When treating with adagrasib, patients are advised to follow their doctor's recommendations and take their medication on time. If any discomfort or side effects occur during treatment, please consult your doctor in time.

Overall, the onset of action of adagrasiib varies from individual to individual, but it usually takes weeks to months to see significant therapeutic effects. Please work closely with your doctor and follow your doctor's recommendations for treatment.